To divide neonates under which category of severity of acute respiratory disease they belong to using a definition put forward for it.

Not Applicable

Completed

• Conditions: Health Condition 1: J22- Unspecified acute lower respiratory infection

• Registration Number: CTRI/2019/04/018417
• Lead Sponsor: A

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2020-01-05
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 58

Inclusion Criteria

All preterm and term infants with

• Meconium aspiration syndrome (MAS)

• Sepsis

• Pneumonia

• Other respiratory conditions( Lung haemorrhage , Aspiration )

Exclusion Criteria

1.Hyaline Membrane Disease defined as:

Mandatory criteria: defined as respiratory distress syndrome appearing within the first

24 hours of life, with response to surfactant and / or volume recruitment. Additional

criteria: Lung imaging Supporting the diagnosis and / or lamellar body counts < 30,000 /

mm3.

2. Transient tachypnea of the neonate (wet lung) defined as:

Mandatory criteria: defined as mild (Silverman score <=3) respiratory distress appearing

within the first 24 hours of life and ending within the first 48 hours of life, needing only

oxygen administration and / or CPAP. Additional criteria: Lung imaging Supporting the

diagnosis and / or lamellar body counts > 30,000 / mm3.

• 3. Patients beyond the first month of life

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To classify infants according to Montreux Definition of neonatal ARDSTimepoint: Within 1 week

Secondary Outcome Measures

Name	Time	Method
â?¢ Mortality <br/ ><br>â?¢ duration of ICU stay, the total duration of ventilation, the total duration of oxygen <br/ ><br>therapy, Oxygen-dependency and/or type of respiratory support at d28 and 36 postTimepoint: 1 week